ESCC showed frequent genomic amplifications of CCND1 and SOX2, and TP63, whereas ERBB2, VEGFA and GATA4, and GATA6 were more commonly amplified in EAC [47]. This evidence concerns the gene GATA6 and esophageal squamous cell carcinoma.